MYELODYSPLASIA WITH BONE-MARROW LYMPHOCYTOSIS AND FIBROSIS MIMICKING RECURRENT HODGKINS-DISEASE

被引:4
作者
GOTTLIEB, CA [1 ]
MAEDA, K [1 ]
HAWLEY, RC [1 ]
ABRAHAM, JP [1 ]
机构
[1] HENRY FORD HOSP,DEPT HEMATOL,DETROIT,MI 48202
关键词
D O I
10.1093/ajcp/91.1.6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:6 / 11
页数:6
相关论文
共 33 条
[1]  
AUCLERC G, 1979, CANCER-AM CANCER SOC, V44, P2017, DOI 10.1002/1097-0142(197912)44:6<2017::AID-CNCR2820440609>3.0.CO
[2]  
2-A
[3]  
AUCLERC G, 1979, CANCER CHEMOTH PHARM, V2, P189
[4]  
BACCARANI M, 1980, CANCER, V46, P1735, DOI 10.1002/1097-0142(19801015)46:8<1735::AID-CNCR2820460806>3.0.CO
[5]  
2-3
[6]  
BOIVIN JF, 1984, JNCI-J NATL CANCER I, V72, P233
[7]  
Brunning R D, 1979, Pathol Annu, V14 Pt 1, P1
[8]   RISK OF LEUKEMIA IN PATIENTS TREATED FOR HODGKINS-DISEASE [J].
BRUSAMOLINO, E ;
LAZZARINO, M ;
SALVANESCHI, L ;
CANEVARI, A ;
MORRA, E ;
CASTELLI, G ;
PAGNUCCO, G ;
ISERNIA, P ;
BERNASCONI, C .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (03) :237-242
[9]  
CADMAN EC, 1977, CANCER-AM CANCER SOC, V40, P1280, DOI 10.1002/1097-0142(197709)40:3<1280::AID-CNCR2820400343>3.0.CO
[10]  
2-A